Short interest for WisdomTree BioRevolution Fund gives investors a sense of the degree to which investors are betting on the decline of WisdomTree BioRevolution Fund's stock. Short interest data is updated every two weeks.

WisdomTree BioRevolution Fund (BATS:WDNA), Short Interest Report

WisdomTree BioRevolution Fund

News

Astrazeneca Disclosed Latest Research Across Key Respiratory And Immune-mediated Diseases At ATS 2024 Showcasing Strength Of Its Broad Pipeline And Portfolio

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHTX#NASDAQ">FHTX</a>) with a Buy and maintains $20 price target.

Price Target

Reiteration

Analyst Ratings

FHTX

HC Wainwright & Co. Reiterates Buy on Foghorn Therapeutics, Maintains $20 Price Target

Baird analyst Luke Junk maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Neutral and lowers the price target from $67 to $65.

THRM

Baird Maintains Neutral on Gentherm, Lowers Price Target to $65

SKYT

SkyWater Technology And Lumotive Announced A Collaboration For The Production Implementation Of Lumotive's Groundbreaking Solid-state Optical Beamforming Technology In SkyWater's Manufacturing Environment

WIIM

SISI

Shineco shares are trading higher after the company announced that its subsidiaries Fuzhou Medashan Biotechnology and Kaifeng Yixi Biotechnology invented a new natural active water-soluble product.

Exxon Mobil Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) reportedly plans to shut down two offshore oil production projects in Guyana for two weeks each, between July and August, to connect a natural gas pipeline.
The company&#8217;s country head&nbsp;Alistair&nbsp;Routledge&nbsp;stated&nbsp;that the company&nbsp;will&nbsp;halt production to fulfill a commitment made with local authorities to have the pipeline connected by&nbsp;year end, despite delays on the government-run onshore part of the project, reported Reuters.
Routledge added that&nbsp;the&nbsp;offshore portion of the about $1 billion pipeline under construction&nbsp;by Exxon&nbsp;is 70% complete.
At a press conference, Routledge said, &#8220;the company&nbsp;stopped revising estimates for potential recoverable resources as it works to quantify actual reserves, an industry metric that considers how much of the oil and gas underground can be commercially developed.&#8221;
&#8220;Our greater focus now is on how&nbsp;do&nbsp;we move&nbsp;resource&nbsp;to&nbsp;reserves,&nbsp;because that&#8217;s what generates revenue for the country.&#8221;&nbsp;
As per the report, the 140-mile (225-km) pipeline will feed Guyana&#8217;s $1.9 billion gas-to-power project to end the country&#8217;s dependence on imported fuels and lower energy costs for residents.
Last month, Exxon and&nbsp;Hess Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HES#NYSE">HES</a>)&nbsp;made a final investment decision for the Whiptail development offshore Guyana following receiving the required<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38221117/guyanas-oil-spigot-wide-open-exxon-hess-sanction-massive-12-7b-oil-project" rel="noreferrer noopener">&nbsp;government and regulatory approvals</a>.&nbsp;
Related:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38274712/exxon-taps-technipfmc-for-subsea-gear-in-guyanas-12-7b-whiptail-project" rel="noreferrer noopener">Exxon Taps TechnipFMC For Subsea Gear In Guyana&#8217;s $12.7B Whiptail&nbsp;Project</a>
As previously said, the proposed pipeline would connect offshore production vessels to a power plant and a natural gas processing facility.&nbsp;The power plant and transmission lines will&nbsp;not&nbsp;be fully operational&nbsp;before&nbsp;end-2025.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38485789/turkey-reportedly-turns-east-for-gas-reportedly-eyes-exxon-deal-to-ditch-russia" rel="noreferrer noopener">Turkey Reportedly Turns East For Gas, Reportedly Eyes Exxon Deal To Ditch Russia</a>
Last week, Exxon Mobil&nbsp;beat Q1 revenue expectations, reporting $83.083 billion, exceeding&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38459221/exxon-mobils-stock-slides-following-q1-earnings-heres-why" rel="noreferrer noopener">consensus by nearly $5 billion</a>.
Investors can gain exposure to the XOM stock via&nbsp;Energy&nbsp;Select Sector&nbsp;SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)&nbsp;and&nbsp;IShares U.S. Energy ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYE#NYSE">IYE</a>).
Price Action: XOM shares are down 0.29% at $117.93 premarket at the last check Wednesday.
Photo: Del Henderson Jr. via Shutterstock

Equities

Large Cap

Media

iShares Dow Jones US Energy Sector Index Fund

Exxon To Shut Down Two Oil Projects For Pipeline Connection: Report

NOTE

FiscalNote Announced Expansion and Modernization of U.S. Presidential Election Coverage by Adding AI-Powered and Data Driven Analysis on Roll Call

Guidance

Marriott International Sees Q2 2024 Adj. EPS $2.43-$2.48 Vs $2.52 Estimate

Baird analyst Peter Arment maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Outperform and raises the price target from $145 to $180.

LDOS

Baird Maintains Outperform on Leidos Holdings, Raises Price Target to $180

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) with a Buy and lowers the price target from $88 to $85.

MMSI

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $85

TLRY

Widmer Brothers Brewing, A Subsidiary Of Tilray Brands, Launched A New Hefe Variety 12 Pack, Showcasing A Wide Range Of Delicious Wheat Beer Style Brews

PLTN

Plutonian Acquisition Corp shares are trading higher after the company announced that shareholders approved a merger with Big Tree Cloud Holdings.

ONEW

OneWater Marine Announced The Completion Of The Previously Announced Acquisition Of Garden State Yacht Sales

Baird analyst Michael Halloran maintains Flowserve (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) with a Neutral and raises the price target from $50 to $57.

Baird Maintains Neutral on Flowserve, Raises Price Target to $57

ALTR

Altair Announced The Acquisition Of Research In Flight For An Undisclosed Amount

Baird analyst Ghansham Panjabi maintains Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) with a Outperform and raises the price target from $90 to $100.

Baird Maintains Outperform on Crown Holdings, Raises Price Target to $100

DPSI

DecisionPoint Systems shares are trading higher after the company announced that it entered into a definitive agreement to merge with an affiliate of Barcoding Holdings.

Baird analyst Jeff Johnson maintains Stryker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>) with a Outperform and raises the price target from $367 to $378.

Baird Maintains Outperform on Stryker, Raises Price Target to $378

AKTS

Akoustis Technologies Announced The Integration Of Four High-performance Patented XBAW Filters Into Two New Platforms With A Tier-1 Network Infrastructure Customer

VRSK

Verisk Analytics Reiterates FY24 Revenue Of $2.84B-$2.90B Vs. $2.88B Estimate, Sees Diluted Adjusted EPS Of $6.30-$6.60 Vs. $6.51 Estimate

Horiba: Wonderful Japanese Company At A Very Attractive Price

Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week